Gregory Brown
Président chez LISATA THERAPEUTICS, INC.
Fortune : 426 525 $ au 30/04/2024
Profil
Gregory B.
Brown is the founder of Healthcare Royalty Management LLC, which was founded in 2007.
He is currently the Chief Executive Officer & Director at Memgen, Inc. since 2020, Chairman at Aquestive Therapeutics, Inc. since 2007, Chairman at Lisata Therapeutics, Inc. since 2016, Director at Oscient Pharmaceuticals Corp.
since 2006, Director at PharmacoPhotonics, Inc. since 2020, Director at Adimab LLC since 2023, and a member of the Advisory Board at Femhealth Ventures LLC since 2022.
He has previously served as Chairman at Invuity, Inc. from 2014 to 2015, Chairman at Nuron Biotech, Inc., Director at Cambrex Corp.
from 2017 to 2019, Independent Non-Executive Director at Faron Pharmaceuticals Oy from 2017 to 2023, Director at Caladrius Biosciences, Inc. from 2016 to 2017, Director at Vanderbilt Clinical SARL, Partner at Paul Capital Partners LP from 2003 to 2006, Head-Investment Banking & Healthcare at Adams Harkness & Hill Investment Banking from 1997 to 2002, Biotechnology Analyst at Vector Securities LLC from 1992 to 1997, and Vice President-Finance at Vector Securities International, Inc. He also served as a partner at Paul Capital Partners (United Kingdom) from 2003 to 2006.
Dr. Brown holds a doctorate degree from SUNY Upstate Medical University (1979), an undergraduate degree from Yale University (1975), and an MBA degree from Harvard Business School (1992).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/03/2024 | 75 085 ( 0,08% ) | 295 084 $ | 30/04/2024 | |
| 09/01/2024 | 49 414 ( 0,59% ) | 131 441 $ | 30/04/2024 |
Postes actifs de Gregory Brown
| Sociétés | Poste | Début |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Président | 01/04/2024 |
| LISATA THERAPEUTICS, INC. | Président | 10/01/2016 |
Femhealth Ventures LLC
 Femhealth Ventures LLC Investment ManagersFinance Femhealth Ventures LLC (Femhealth Ventures) is a venture capital firm founded in 2020 by Maneesha Ghiya. The firm is headquartered in New York. | Consultant / Advisor | 01/01/2022 |
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Directeur Général | 01/02/2020 |
PharmacoPhotonics, Inc.
 PharmacoPhotonics, Inc. Electronic Equipment/InstrumentsElectronic Technology PharmacoPhotonics, Inc. is a medical technology company. Its technology measures blood volume and kidney function and it impacts heart failure, cardio-renal, major surgery, sepsis, critical care, and kidney disease patients. The company was founded in 2006 and is headquartered in Indianapolis, IN. | Directeur/Membre du Conseil | 01/01/2020 |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Directeur/Membre du Conseil | 01/08/2006 |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Fondateur | 01/01/2007 |
Adimab LLC
 Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Directeur/Membre du Conseil | 01/01/2023 |
Anciens postes connus de Gregory Brown
| Sociétés | Poste | Fin |
|---|---|---|
| FARON PHARMACEUTICALS OY | Directeur/Membre du Conseil | 24/03/2023 |
| ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formation de Gregory Brown
| Yale University | Undergraduate Degree |
| SUNY Upstate Medical University | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Health Technology |
| FARON PHARMACEUTICALS OY | Health Technology |
| LISATA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 16 |
|---|---|
Paul Capital Partners LP
 Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Finance |
Vector Securities LLC
 Vector Securities LLC Investment Banks/BrokersFinance Part of Prudential Financial, Inc., Vector Securities LLC is a company that provides investment banking services. The company is based in Deerfield, IL. Vector Securities was acquired by Prudential Securities on June 09, 1999. | Finance |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Finance |
Adams Harkness & Hill Investment Banking
 Adams Harkness & Hill Investment Banking Investment ManagersFinance Part of Canaccord Genuity Group, Inc., Adams Harkness & Hill Investment Banking is a company based in Boston, MA. | Finance |
Nuron Biotech, Inc.
 Nuron Biotech, Inc. BiotechnologyHealth Technology Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA. | Health Technology |
Invuity, Inc.
 Invuity, Inc. Medical DistributorsDistribution Services Invuity, Inc. operates as a medical technology company. The firm engages in the development and marketing of surgical and medical devices. Its products include retractors, handhelds and drop-ins under the Photonics and PhotonBlade brands. The company was founded by Kenneth B. Trauner and Alex Vayser on November 29, 2004 and is headquartered in San Francisco, CA. | Distribution Services |
| Vector Securities International, Inc. | Finance |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
Vanderbilt Clinical SARL
 Vanderbilt Clinical SARL Financial ConglomeratesFinance Vanderbilt Clinical SARL engaged in in the acquisition, management, and realization of investment profits. The company was founded on December 6, 2010 and was headquartered in Luxembourg. | Finance |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
PharmacoPhotonics, Inc.
PharmacoPhotonics, Inc. Electronic Equipment/InstrumentsElectronic Technology PharmacoPhotonics, Inc. is a medical technology company. Its technology measures blood volume and kidney function and it impacts heart failure, cardio-renal, major surgery, sepsis, critical care, and kidney disease patients. The company was founded in 2006 and is headquartered in Indianapolis, IN. | Electronic Technology |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Health Technology |
Paul Capital Partners (United Kingdom)
 Paul Capital Partners (United Kingdom) Investment ManagersFinance Part of Paul Capital Partners LP, Paul Capital Partners (United Kingdom) is a British company that provides investment consulting services. The company is based in London, UK. | Finance |
Femhealth Ventures LLC
Femhealth Ventures LLC Investment ManagersFinance Femhealth Ventures LLC (Femhealth Ventures) is a venture capital firm founded in 2020 by Maneesha Ghiya. The firm is headquartered in New York. | Finance |
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Health Technology |
